Killer-cell inhibitory receptors, CD158a/b, are upregulated by interleukin-2, but not interferon-γ or interleukin-4

Mediators of Inflammation

Volumn 8, Issue 6, 1999, Pages 313-318

  Kogure, Toshiaki ^a   Fujinaga, Hiroshi ^a   Niizawa, Atsushi ^a   Hai, Le Xuan ^a   Shimada, Yutaka ^a   Ochiai, Hiroshi ^a   Terasawa, Katsutoshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LYMPHOCYTE RECEPTOR;

ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL KILLING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0033501307     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359990324     Document Type: Article

References (29)

1. 1. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990: 11: 237-44.
2. 2. Wagtmann N, Biassoni R, Cantoni C et al. Molecular clones of the p58 NK cell receptor reveal immunoglobuline-related molecules with diversity in both the extra-and intracellular domains. Immunity 1995: 2: 439-49.
3. 3. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995: 268: 405-408.
4. 4. D'andrea A, Chang C, Franz-Bacon K, McClanahan T, Phillips JH, Lanier LL. Molecular cloning of NKB1 a natural killer cell receptor for HLA-B allotypes J Immunol 1995: 155: 2306-10.
5. 5. Binstadt BA, Brumbaugh KM, Dick CJ et al. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 1996: 5: 629-38.
6. 6. Vivier E, Daeron M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997: 18: 286-91.
7. 7. Moretta L, Ciccone E, Moretta A, Hoglund P, Ohlen C, Karre K. Allo-recognition by NK cells: nonself or self. Immunol Today 1992: 13: 300-3.
8. 8. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993: 11: 613-635.
9. 9. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996: 17: 86-91.
10. 10. Grimm EA, Robb RJ, Roth JA et al. Lymphokine-activated killer cell phenomenon III. Evidence that IL-2 is sufficient for direct activated killer cells. J Exp Med 1983: 158: 1356-61.
11. 11. Robertson MJ, Manley TJ, Donahue C, Levine H, Ritz J. Co-stimulatory signals are required for optimal proliferation of human natural killer cells. J Immunol 1993: 150: 1705-14.
12. 12. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989: 47: 187-376.
13. 13. Sayers TJ, Mason AT, Ortaldo JR. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. J Immunol 1986: 136: 2176-80.
14. 14. Brooks B, Chapman K, Lawry J, Meager A, Rees RC. Suppression of lymphokine-activated killer cell induction mediated by interleukin-4 and transforming growth factor-β 1: effect of addition of exogenous tumor necrosis factor alpha and interferon-gamma, and measurement of their endogenous production. Clin Exp Immunol 1990: 82: 583-9.
15. 15. Nagler A, Lanier LL, Phillips JH. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation. J Immunol 1988: 141: 2349-51.
16. 16. Frohhn C, Schlenke P, Kirscner H. The repertoire of HLA-Cw-specific NK cell receptors CD158a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunol 1997: 92: 567-70.
17. 17. Ciccone E, Pende D, Viale O et al. Involvement of HLA class I alleles in natural killer cell specific functions: expression of HLA Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (Specificity 2). J Exp Med 1992: 176: 963-71.
18. 18. Colonna M. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol Rev 1997: 155: 127-33.
19. 19. Morreta A, Biassoni R, Bottino C et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997: 155: 105-17.
20. 20. Ross G, Winchester RJ. Methods for enumerating lymphocyte population. In: Rose NR, Friedmann H, eds, Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology, 1986: 213.
21. 21. Pflueger E, Mueller EA, Anderer FA. Preservation of cytotoxic function during multi-cycle immunomagnetic cell separations of human NK cells using a new type of magnetic bead. J Immunol Methods 1990: 129: 165-73.
22. 22. Morreta A, Tambussi G, Bottino C et al. A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. J Exp Med 1990: 171: 695-714.
23. 23. Morreta A, Bottino C, Penda D et al. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK colnes and ability to mediate specific alloantigen recognition. J Exp Med 1990: 172: 1589-98.
24. 24. Smith KA. Interleukin-2: inception, impact, and implications. Science 1988: 240: 1169-1176.
25. 25. Storkus WJ, Alexander J, Payne JA, Cresswell P, Dawson JR. The alpha 1/alpha 2 domains of class 1 HLA molecules confer resistance to natural killing. J Immunol 1989: 143: 3853-957.
26. 26. Raulet DH, held W. natural killer cell receptors: the offs and ons of NK cell recognition. Cell 1995: 82: 697-700.
27. 27. Daeron M. Fc receptor biology. Annu Rev Immunol 1997: 15: 203-34.
28. 28. Handgretinger R, Kimmig A, Lang P et al. Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to Interleukin-2-activated natural killer cells. Nat Immun Cell Growth Regul 1989: 8. 189-96.
29. 29. Gardiner CM, Reen DJ. Differential cytokine regulation of natural killer cell-mediated necrotic and apoptotic cytotoxicity. Immunol 1998: 93: 511-17.